Ubs Group Ag X Biotech Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in X Biotech Inc. stock. As of the latest transaction made, Ubs Group Ag holds 14,425 shares of XBIT stock, worth $96,070. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,425

Previous 10,618 35.85%

Holding current value

$96,070

Previous $54,000 105.56%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.55 - $7.95 $21,128 - $30,265	3,807 Added 35.85%	14,425 $111,000
Q2 2024 Aug 13, 2024	BUY	$4.54 - $9.89 $14,863 - $32,379	3,274 Added 44.58%	10,618 $54,000
Q1 2024 May 13, 2024	SELL	$4.03 - $8.13 $8,483 - $17,113	-2,105 Reduced 22.28%	7,344 $59,000
Q4 2023 Feb 09, 2024	BUY	$3.56 - $4.65 $14,852 - $19,399	4,172 Added 79.06%	9,449 $37,000
Q3 2023 Nov 09, 2023	SELL	$4.02 - $5.81 $3,268 - $4,723	-813 Reduced 13.35%	5,277 $21,000
Q2 2023 Aug 11, 2023	BUY	$3.06 - $6.38 $3,234 - $6,743	1,057 Added 21.0%	6,090 $36,000
Q1 2023 May 12, 2023	SELL	$3.22 - $4.72 $2,782 - $4,078	-864 Reduced 14.65%	5,033 $17,000
Q4 2022 Feb 08, 2023	BUY	$3.03 - $3.79 $1,860 - $2,327	614 Added 11.62%	5,897 $20,000
Q3 2022 Nov 10, 2022	SELL	$3.58 - $5.88 $9,952 - $16,346	-2,780 Reduced 34.48%	5,283 $19,000
Q2 2022 Aug 10, 2022	SELL	$5.13 - $9.2 $1,990 - $3,569	-388 Reduced 4.59%	8,063 $45,000
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $27,069 - $36,687	-3,133 Reduced 27.05%	8,451 $73,000
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $64,429 - $94,555	5,884 Added 103.23%	11,584 $129,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $26,405 - $37,191	2,039 Added 55.7%	5,700 $74,000
Q2 2021 Aug 13, 2021	SELL	$15.83 - $17.84 $52,587 - $59,264	-3,322 Reduced 47.57%	3,661 $61,000
Q1 2021 May 12, 2021	SELL	$15.92 - $20.3 $31,266 - $39,869	-1,964 Reduced 21.95%	6,983 $120,000
Q4 2020 Feb 11, 2021	BUY	$15.65 - $19.92 $92,288 - $117,468	5,897 Added 193.34%	8,947 $140,000
Q3 2020 Nov 12, 2020	SELL	$13.97 - $21.16 $61,481 - $93,125	-4,401 Reduced 59.07%	3,050 $58,000
Q2 2020 Jul 31, 2020	SELL	$10.39 - $16.07 $7,148 - $11,056	-688 Reduced 8.45%	7,451 $102,000
Q1 2020 May 01, 2020	SELL	$8.89 - $24.94 $102,715 - $288,156	-11,554 Reduced 58.67%	8,139 $86,000
Q4 2019 Feb 14, 2020	BUY	$8.33 - $19.95 $121,568 - $291,150	14,594 Added 286.21%	19,693 $368,000
Q3 2019 Nov 14, 2019	BUY	$6.86 - $10.46 $34,979 - $53,335	5,099 New	5,099 $53,000
Q1 2019 May 14, 2019	SELL	$5.05 - $11.62 $52,989 - $121,928	-10,493 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.22 - $6.27 $33,787 - $65,791	10,493 New	10,493 $53,000
Q2 2018 Aug 14, 2018	SELL	$4.04 - $5.13 $771 - $979	-191 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.92 - $5.35 $748 - $1,021	191 New	191 $1,000
Q4 2017 Feb 14, 2018	SELL	$3.9 - $4.66 $893 - $1,067	-229 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.14 - $5.12 $948 - $1,172	229	229 $1,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.87M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account